Novo Nordisk Escalates Research Efforts for Curing Type 1 Diabetes
While there is no doubt that Type 1 diabetes has affected millions of people around the world, a recent report confirmed that Danish drug company Novo Nordisk is making efforts in the direction of developing a cure for the disease.
On the same lines, the company under the supervision of Dr. Matthias von Herrath, Director of the nonprofit Center for Type 1 Diabetes Research in La Jolla, California, would start a research centre in Novo Nordisk's facilities in South Lake Union next month.
While there are already 70 people employed for the same, there are chances that there would be some 10 to 12 researchers hired for the same centre so that efforts could be stepped up. There is need that efforts are being consistently made in the direction of finding some sort of cure for the disease which makes the body's immune system to attack cells in the pancreas, which are responsible for producing insulin. The most not worthy point with this disease is that it has nothing to do with oneâ€™s sedentary lifestyle or eating habits.
While plans of Novo Nordisk all set to expand in Seattle, it has certainly set an example for others to come forward and follow steps which can actually bring some sort of hope for those who are lingering with the disease.